The Role of Liver Biopsies in Psoriatic Patients Receiving Long-term Methotrexate Treatment: Improvement in Liver Abnormalities After Cessation of Treatment

Archives of Dermatology

Volumn 125, Issue 9, 1989, Pages 1218-1224

  Newman, Michael ^a   Auerbach, Robert ^a   Feiner, Helen ^a   Holzman, Robert S ^a   Shupack, Jerome ^a   Migdal, Phyllis ^a   Culubret, Monse ^a   Camuto, Patricia ^a   Tobias, Hillel ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

HISTOLOGY; HUMAN; HUMAN CELL; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; BIOPSY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; LIVER; LIVER FUNCTION TESTS; MALE; METHOTREXATE; MIDDLE AGE; PSORIASIS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0024444047     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1989.01670210056007     Document Type: Article

References (18)

1. Hanno R, Gruber GG, Owen LG, Callen JP. Methotrexate in psoriasis: a brief review of indications, usage, and complications of methotrexate therapy. J Am Acad Dermatol. 1980;2:171–174.
2. Roenigk HH Jr, Haserick JR, Curtis GH. Methotrexate for psoriasis. Cleve Clin J Med. 1983;50:101–105.
3. Weinstein GD. Commentary: three decades of folic acid antagonists in dermatology. Arch Dermatol. 1983;119:525–527.
4. Tobias H, Auerbach R. Hepatotoxicity of long-term methotrexate therapy for psoriasis. Arch Intern Med. 1973;132:391–396.
5. Weinstein G, Roenigk H, Maibach H, Cosmides J. Psoriasis-liver-methotrexate interactions. Arch Dermatol. 1973;108:35–42.
6. Reese LT, Grisham JW, Aach RD, Eisen AZ. Effects of methotrexate on the liver in psoriasis. J Invest Dermatol. 1974;62:597–602.
7. Zachariae H, Grunnet E, Sogaard H. Liver biopsy in methotrexate-treated psoriatics—a re-evaluation. Acta Derm Venereol (Stockh). 1975;55:291–296.
8. Nyfors A, Poulsen H. Liver biopsies from psoriatics related to methotrexate therapy. Acta Pathol Microbiol Immunol Scand A. 1976;84:262–270.
9. Nyfors A. Liver biopsies from psoriatics related to methotrexate therapy. Acta Pathol Microbiol Immunol Scand A. 1977;85:511–518.
10. Robinson JK, Baughman RD, Auerbach R, Cimis RJ. Methotrexate hepatotoxicity in psoriasis: consideration of liver biopsies at regular intervals. Arch Dermatol. 1980;116:413–415.
11. Zachariae H, Kragballe K, Søgaard H. Methotrexate induced liver cirrhosis: studies including serial liver biopsies during continued treatment. Br J Dermatol. 1980;102:407–412.
12. Ashton RE, Millward-Sadler GH, White JE. Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis. J Invest Dermatol. 1982;79:229–232.
13. Van de Kerkhof PCM, Hoefnagels WHL, Van Haelst UJGM, Mali JWH. Methotrexate maintenance therapy and liver damage in psoriasis. Clin Exp Dermatol. 1985;10:194–200.
14. Roenigk HH Jr, Auerbach R, Maibach HI, Weinstein GD. Methotrexate in psoriasis-revised guidelines. J Am Acad Dermatol. 1988;19:145–156.
15. Weinstein GD, Frost P. Methotrexate for psoriasis: a new therapeutic schedule. Arch Dermatol. 1971;103:33–38.
16. Health and Public Policy Committee, American College of Physicians. Position paper: methotrexate in rheumatoid arthritis. Ann Intern Med. 1987;107:418–419.
17. Zachariae H, Sogaard H. Methotrexate-induced liver cirrhosis: a follow-up. Dermatologica. 1987;175:178–182.
18. Creswell SN, Burrows D. Liver biopsies in psoriatics: complications and evaluation. Int J Dermatol. 1980;19:217–219.